SARS-CoV-2 Neutralizing Antibodies 2.0

被引:0
|
作者
Wang, Youchun [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming 650118, Peoples R China
来源
VIRUSES-BASEL | 2024年 / 16卷 / 11期
关键词
OPTIMIZATION;
D O I
10.3390/v16111791
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Protective non-neutralizing SARS-CoV-2 monoclonal antibodies
    Izadi, Arman
    Nordenfelt, Pontus
    TRENDS IN IMMUNOLOGY, 2024, 45 (08) : 609 - 624
  • [42] Outliers Matter-Correlation between S1 IgG SARS-CoV-2 Antibodies and Neutralizing SARS-CoV-2 Antibodies
    Hocher, Berthold
    Schonbrunn, Anne
    Chen, Xin
    Kramer, Bernhard K.
    von Baehr, Volker
    MICROORGANISMS, 2022, 10 (10)
  • [43] Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
    Lin, Qingqing
    Zhu, Li
    Ni, Zuowei
    Meng, Haitao
    You, Liangshun
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (05) : 821 - 822
  • [44] VIRUSES Neutralizing SARS-CoV-2
    Poeschla, Eric
    ELIFE, 2020, 9 : 1 - 4
  • [45] SARS-CoV-2 spike S2-specific neutralizing antibodies
    Li, Chia-Jung
    Chang, Shih-Chung
    EMERGING MICROBES & INFECTIONS, 2023, 12 (02)
  • [46] Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
    Tani, Hideki
    Kimura, Miyuki
    Tan, Long
    Yoshida, Yoshihiro
    Ozawa, Tatsuhiko
    Kishi, Hiroyuki
    Fukushi, Shuetsu
    Saijo, Masayuki
    Sano, Kaori
    Suzuki, Tadaki
    Kawasuji, Hitoshi
    Ueno, Akitoshi
    Miyajima, Yuki
    Fukui, Yasutaka
    Sakamaki, Ippei
    Yamamoto, Yoshihiro
    Morinaga, Yoshitomo
    VIROLOGY JOURNAL, 2021, 18 (01)
  • [47] Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
    Hideki Tani
    Miyuki Kimura
    Long Tan
    Yoshihiro Yoshida
    Tatsuhiko Ozawa
    Hiroyuki Kishi
    Shuetsu Fukushi
    Masayuki Saijo
    Kaori Sano
    Tadaki Suzuki
    Hitoshi Kawasuji
    Akitoshi Ueno
    Yuki Miyajima
    Yasutaka Fukui
    Ippei Sakamaki
    Yoshihiro Yamamoto
    Yoshitomo Morinaga
    Virology Journal, 18
  • [48] SARS-CoV-2 nanobodies 2.0
    Fabien Labroussaa
    Joerg Jores
    Signal Transduction and Targeted Therapy, 6
  • [49] SARS-CoV-2 nanobodies 2.0
    Labroussaa, Fabien
    Jores, Joerg
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [50] SARS-CoV-2-Neutralizing Antibodies
    Liu, Yawen
    Nie, Jianhui
    VACCINES, 2024, 12 (11)